BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 11, 2011
View Archived Issues
Carnosic acid is neuroprotective in rat model of Alzheimer's disease
Read More
UCB reviews pipeline progress of 2010
Read More
NeuroDerm advances phase I/II trial of ND-0611 dermal patch for Parkinson's disease
Read More
Genus Oncology's GO-203-2c receives FDA orphan drug status in pancreatic cancer
Read More
Novel putative biomarkers for endometrial ovarian carcinoma identified
Read More
Aerie Pharma secures financing to support advancement of glaucoma portfolio
Read More
First-in-human data on TUTI-16 support its use in asymptomatic HIV-1-infected subjects
Read More
Cell Therapeutics reports final design of pivotal pixantrone trial
Read More
Merck & Co. presents novel renin inhibitors
Read More
Phenex Pharma patents new farnesoid X receptor agonists
Read More
PharmaMar reports novel inhibitors of HIV reverse transcriptase
Read More
Novartis presents novel inhibitors of hepatocyte growth factor receptor
Read More
Sinovac Biotech submits application for pneumococcal conjugate vaccine trials in China
Read More
Plexxikon begins phase II trial of PLX-3397 in Hodgkin's lymphoma
Read More
FDA accepts Merck & Co.'s tafluprost NDA to treat elevated intraocular pressure
Read More
Boehringer Ingelheim patents new phosphodiesterase 9A inhibitors
Read More
Enrollment complete in ERYtech Pharma's phase II Graspa trial in acute lymphoblastic leukemia
Read More
Santarus begins phase I trial of SAN-300 for rheumatoid arthritis
Read More
Adamis Pharma files IND with FDA for APC-100 in prostate cancer
Read More
Roche reports on new gamma-secretase modulators for treatment of Alzheimer's disease
Read More
Genentech reports moderate to low risk of interactions between GDC-0941 and paclitaxel
Read More
Insys Therapeutics submits NDA to FDA for fentanyl sublingual spray
Read More
Eisai and Epizyme enter worldwide partnership for EZH2-targeting anticancer therapeutics
Read More
Vertex Pharma plans phase IIb VX-765 trial in epilepsy following phase IIa data
Read More
Biothera acquires Antisoma's anticancer monoclonal antibody AS-1402
Read More
